← Leaderboards
Caroline Helene Shiboski
University Of California San Francisco
$6,767,700
Attributed
$10,954,875
Total exposure
6
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.4M · FY2005–25$2.5M$1.9M$1.3M$625K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$10,954,875 · 6
By mechanism
UC2$5,801,518 · 1
U01$4,012,846 · 1
K23$602,311 · 1
R03$474,500 · 2
R56$63,700 · 1
Top collaborators
- Alan N Baer5 shared
- A. Darise Farris5 shared
- Blake Matthew Warner3 shared
- Lindsey Ann Criswell1 shared
Most similar at University Of California San Francisco
Same institution · by research overlap
- Nancy E. Lane$24,503,745
- Lindsey Ann Criswell$20,453,502
- Daniel Fried$15,008,641
- Neetu Gupta$6,410,156
- Susan J. Fisher$38,160,909
Others in their field
Top investigators on “Epidemiology”
- David Heimbrook · Leidos Biomedical Research, Inc.$390,770,069
- George R Seage · Abt Associates, Inc.$299,251,523
- Jeffrey P Krischer · University Of South Florida$264,076,260
- Barbara Driver · Westat, Inc.$221,167,491
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$206,739,528
- James Dennis Neaton · Northwestern University$203,539,316
Research focus
EpidemiologyParticipantClinical TrialsNational Institute Of Dental And Craniofacial ResearchGenomicsGenome Wide Association StudyInternationalEuropeanGenetic HeterogeneityGeneticCollegePathogenesisAmericanFundingClinical DataClassificationDna MethylationBiologicalCollaborationsCohortDiagnosisFutureCellsPathway Interactions
Grant awards (20)
Sjögrenâs Team for Accelerating Medicines Partnership (STAMP)$1,749,759
UC2 · FY2025 · DE · contact PI
Sjögrenâs Team for Accelerating Medicines Partnership (STAMP)$951,759
UC2 · FY2024 · DE · contact PI
Sjögren's International Collaborative Clinical Alliance Next Generation Studies (SICCA-NextGen)$791,345
U01 · FY2024 · DE · contact PI
Sjögrenâs Team for Accelerating Medicines Partnership (STAMP)$600,000
UC2 · FY2024 · DE · contact PI
Sjögrenâs Team for Accelerating Medicines Partnership (STAMP)$1,600,000
UC2 · FY2023 · DE · contact PI
Sjögren's International Collaborative Clinical Alliance Next Generation Studies (SICCA-NextGen)$807,498
U01 · FY2023 · DE · contact PI
Sjögrenâs Team for Accelerating Medicines Partnership (STAMP)$900,000
UC2 · FY2022 · DE · contact PI
Sjögren's International Collaborative Clinical Alliance Next Generation Studies (SICCA-NextGen)$799,423
U01 · FY2022 · DE · contact PI
Sjögren's International Collaborative Clinical Alliance Next Generation Studies (SICCA-NextGen)$807,498
U01 · FY2021 · DE · contact PI
Epigenetic and transcriptomic determinants of Sjogren's Syndrome subtypes utilizing data from the Sjogren's International Collaborative Clinical Alliance (SICCA) cohort$161,500
R03 · FY2021 · DE · contact PI
Sjögren's International Collaborative Clinical Alliance Next Generation Studies (SICCA-NextGen)$807,082
U01 · FY2020 · DE · contact PI
Epigenetic and transcriptomic determinants of Sjogren's Syndrome subtypes utilizing data from the Sjogren's International Collaborative Clinical Alliance (SICCA) cohort$161,500
R03 · FY2020 · DE · contact PI
SjÃÂögrenâÃÂÃÂs International Collaborative Clinical Alliance Next Generation Studies (SICCA-NextGen)$63,700
R56 · FY2019 · DE · contact PI
ORAL DISEASE AMONG RENAL TRANSPLANT RECIPIENTS$105,706
K23 · FY2005 · DE
ORAL DISEASE AMONG RENAL TRANSPLANT RECIPIENTS$125,946
K23 · FY2004 · DE
Oral Health Outcomes in Pediatric Transplant Recipients$75,750
R03 · FY2004 · DE
ORAL DISEASE AMONG RENAL TRANSPLANT RECIPIENTS$125,132
K23 · FY2003 · DE
Oral Health Outcomes in Pediatric Transplant Recipients$75,750
R03 · FY2003 · DE
ORAL DISEASE AMONG RENAL TRANSPLANT RECIPIENTS$122,894
K23 · FY2002 · DE
ORAL DISEASE AMONG RENAL TRANSPLANT RECIPIENTS$122,633
K23 · FY2001 · DE